Steep Hill Labs opened the first commercial cannabis lab in the United States in 2007. Now, with labs in 4 states (and at least two new locations opening in 2015), 5 Ph.D Scientists on staff and a recently-launched a state-of-the art Genetics Lab , Steep Hill is the country’s leading cannabis analytical lab. In addition to its core testing business, Steep Hill is also innovative product development Lab that has already developed and commercialized two proprietary products: the QuantaCann and the GenKit.
The QuantaCann is an on-site potency and moisture machine that provides important analytical information with respect to marijuana samples in 60 seconds. The QuantaCann was recently featured on CSI Vegas as the scientific equipment used to solve a murder in a marijuana dispensary. The QuantaCann has been approved as meeting the state requirements for the testing of potency, cannabinoid profiles and moisture by the State of New Mexico. The scientists at Steep Hill are busy developing the next generation of QuantaCann which will have no moving parts, an upgraded user interface, a wand for testing concentrates and other exciting features.
The GenKit is the first product offering to come out of our Genetics Lab and was introduced to the market as of March 1, 2015. The GenKit contains 8 test packages which allow growers to clip a tiny portion of a seedling leaf and then send that package to the Lab. Once received, our geneticists are able to identify which plants are male plants. That information is then communicated to the customer through a convenient tracking system and the grower is then able to use this information to cull the male plants much sooner than could be done without the assistance of a genetics lab. This results in the saving of time, energy and resources and increased crop yield.
Steep Hill is investing in its expansion, infrastructure and human capital to maintain its leadership position and to provide the best cannabis science.
Summary
| Prior Year Revenue | Current Year Revenue | Next Year Revenue |
|---|---|---|
| Sign up as Investor | Sign up as Investor | Sign up as Investor |
| Company Age | Employees | Sub-Industry |
|---|---|---|
| 7 years, 8 months | 30 | Other Biotechnology |
Products / Services
Cannabis Testing Services; Genetics Lab; QuantaCann; GenKits
Steep Hill Labs is a commercial cannabis analytical laboratory that tests marijuana and marijuana-derived products to ensure compliance with public safety standards and to provide consumers with information with respect to potency, cannabinoid profile and moisture. Steep Hill has labs in 4 states and will be opening up labs in at least 2 more states in 2015. Steep Hill recently launched a state-of-the-art Genetics Lab and, in addition to its core testing business, Steep Hill is an innovative product development Lab that has already developed and commercialized two proprietary products: the QuantaCann and the GenKit.
The QuantaCann is an on-site instant potency and moisture diagnostic machine. The QuantaCann provides potency, cannabinoid profile and moisture information and was recently approved by the State of New Mexico to conduct state-mandated tests.
The GenKit, provides growers with genetic information regarding their seedlings that assist in cultivation decisions.
Markets
| Market | Annual Size | % Growth Rate |
|---|---|---|
| Legalized Medical and Recreational Marijuana Industry | $3,000,000,000 | 75 % |
Management
Chief Executive Officer
David Lampach
As Co-Founder and Chief Executive Officer of Steep Hill, Mr. Lampach has been a leader in the technological and business advancements of the cannabis analytics and testing market. He developed the first non-Federal medical cannabis potency and microbiological contaminants test methodology used in California, which was the first state to legalize medical cannabis.
While building Steep Hill, Mr. Lampach has provided expert consulting advice to a variety of government agencies, states and local municipalities on effective cannabis testing, quality assurance and regulation, including serving as a member of the Washington State team tasked with designing the state’s framework for legalization under I-502. He also worked with the Mendocino County Sheriff’s Department to help regulate large cannabis cultivation sites under the 9.31 exemption.
General Counsel/Legal Officer
Mitch Kulick
As Steep Hill’s General Counsel, Mr. Kulick manages the company’s contractual relationships with customers, suppliers, and licensees and serves as a member of Steep Hill’s executive management team. He is the company liaison to Steep Hill’s investors and government regulators. In addition, Mr. Kulick works with outside counsel to protect Steep Hill’s intellectual property and business interests.
Prior to joining Steep Hill, Mr. Kulick served for 8 years as the General Counsel and Chief Compliance Officer for Iroquois Capital, a leading hedge fund and private equity fund in New York City. Prior to joining Iroquois, Mr. Kulick worked for the Securities & Exchange Commission where he was a staff attorney in the Enforcement Division of the New York Regional Office. Mr. Kulick’s legal career began in the New York office of Greenberg Traurig. While there, he worked on complex corporate reorganizations, labor disputes and securities litigation matters.
Steep Hill Labs opened the first commercial cannabis lab in the United States in 2007. Now, with labs in 4 states (and at least two new locations opening in 2015), 5 Ph.D Scientists on staff and a recently-launched a state-of-the art Genetics Lab , Steep Hill is the country’s leading cannabis analytical lab. In addition to its core testing business, Steep Hill is also innovative product development Lab that has already developed and commercialized two proprietary products: the QuantaCann and the GenKit.
See Campaign: https://www.equitynet.com/c/steep-hill-labs-inc?s=p
Contact Information:
David Lampach
Mitch Kulick
Tags:
EquityNet, United States, Equity, Biotech, English, California, Industry verticals, Regions, Types of Crowdfunding deal, Pharmaceuticals & Biotech, Language
Source: ICNW
